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Toll-like receptor (TLR) stimulation activates macro-
phages to resist intracellular pathogens. Yet, the
intracellular bacterium Listeria monocytogenes (Lm)
causes lethal infections in spite of innate immune
cell activation. Lm uses direct cell-cell spread to
disseminate within its host. Here, we have shown
that TLR-activated macrophages killed cell-free Lm
but failed to prevent infection by spreading Lm.
Instead, TLR signals increased the efficiency of
Lmspread from ‘‘donor’’ to ‘‘recipient’’macrophages.
This enhancement required nitric oxide (NO) produc-
tion by nitric oxide synthase-2 (NOS2). NO increased
Lmescape from secondary vacuoles in recipient cells
and delayed maturation of phagosomes containing
membrane-like particles that mimic Lm-containing
pseudopods. NO also promoted Lm spread during
systemic in vivo infection, as shown by the fact that
inhibition of NOS2 with 1400W reduced spread-
dependent Lm burdens in mouse livers. These find-
ings reveal amechanismbywhichpathogenscapable
of cell-cell spread can avoid the consequences of
innate immune cell activation by TLR stimuli.
INTRODUCTION
Toll-like receptors (TLR) are pattern recognition receptors that
promote host defense through the activation of inflammatory
responses (Nish andMedzhitov, 2011). The recognition of micro-
bial products by TLRs stimulates the activation of macrophage
antimicrobial mechanisms, including the production of nitric
oxide (NO) by the inducible NO synthetase-2 (NOS2) (Endres
et al., 1997; Gregory et al., 1993; MacMicking et al., 1997; Myers
et al., 2003; Shiloh et al., 1999). TLR activation thus increases the
ability of macrophages to kill phagocytosed bacteria (Myers
et al., 2003; Shiloh et al., 1999). Nonetheless, certain intracellular
pathogens are able to overcome early TLR-dependent immune
cell activation to establish infections in susceptible hosts. The
mechanisms by which these pathogens avoid cellular innate
immunity remain unclear.After infecting an initial cell, many cytosolic intracellular path-
ogens—including Listeria, Shigella, Rickettsia, vaccinia, and
HIV—move directly from this primary infected ‘‘donor’’ cell to
a secondary uninfected ‘‘recipient’’ cell via a process known as
cell-cell spread (spread) (Sattentau, 2008). Spread allows patho-
gens to remain intracellular and thus avoid extracellular defense
mechanisms and humoral immune factors (Sattentau, 2008).
Spread can be divided into three steps: (1) primary infection of
donor cells with escape from the phagosome, polymerization
of host actin, and initiation of intracytoplasmic pathogen move-
ment; (2) formation of membrane-encapsulated pseudopods
that permit transfer of pathogens to uninfected recipient cells;
and (3) pseudopod uptake and the establishment of a productive
secondary infection in recipient cells. Previous work has identi-
fied several pathogen and host factors contributing to the first
two steps in spread. Less is known about host factors involved
in secondary infection, in part because of the difficulty of
quantifying spread and a dearth of high-throughput assays to
measure spread.
The Gram-positive bacterium Listeria monocytogenes (Lm)
is a frequent contaminant of foods and causes gastroenteritis,
meningitis, and abortion in susceptible individuals (Pizarro-
Cerda´ and Cossart, 2009; Wing and Gregory, 2002). During
the first step of spread, Lm is phagocytosed into a primary
vacuolar compartment or phagosome. Maturation of this phag-
osome is controlled by host Rab5a and PKC (Pizarro-Cerda´
and Cossart, 2009; Prada-Delgado et al., 2005). Host g-inter-
feron inducible lysosomal thiol (GILT) activates a secreted
bacterial hemolysin (Hly) that promotes vacuolar rupture and
bacterial escape into the cytoplasm (Singh et al., 2008). Once
in the cytoplasm, Lm produces an actin nucleating protein,
ActA, that co-opts host machinery (ARP 2 and 3, VASP, profilin,
PI 3-kinases, and ezrin) to promote actin-based movement and
the formation of Lm-containing pseudopod projections that are
engulfed by recipient cells (Pizarro-Cerda´ and Cossart, 2009;
Sidhu et al., 2005; Tilney and Portnoy, 1989; Welch et al.,
1998). Lm can grow in the secondary, double-membraned
‘‘phagosomes’’ (Birmingham et al., 2008) or in the cytoplasm
after escape from these phagosomes (Camilli et al., 1993; Gedde
et al., 2000).
Here, we investigated whether and how cell-cell spread
impacted the ability of Lm to avoid the consequences of
TLR-mediated activation. These studies employed a flowImmunity 36, 807–820, May 25, 2012 ª2012 Elsevier Inc. 807
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Nitric Oxide Regulates Lm Spreadcytometry-based approach to quantify cell-cell spread, although
similar results were obtained with more conventional micros-
copy-based and plaquing assays. Paradoxically, whereas TLR
stimulation of macrophages inhibited their ability to be infected
as primary cells (as we confirmed), it enhanced their ability to
be infected as secondary cells via cell-cell spread. Strikingly,
the mechanism for this enhanced infection was dependent on
iNOS-dependent production of NO. NO delayed maturation of
vacuoles containing carboxylated beads, which chemically
resemble the cell-membrane-encapsulated pseudopods formed
by spreading Lm. Consistent with such delayed maturation,
macrophages exposed to NO were more susceptible to cyto-
plasmic infection by spreading Lm. These studies reveal host
pathways that are exploited by intracellular pathogens during
cell-cell spread in order to avoid the consequences of TLR-
induced macrophage activation.
RESULTS
Analysis of Macrophage-to-Macrophage Spread
of Listeria monocytogenes
A flow cytometry-based assay was developed to identify host
factors that alter Lm spread. In one permutation, fluorescently
labeled donor macrophages were infected with green fluores-
cent protein (GFP)-expressing Lm strains (GFP-Lm; see Experi-
mental Procedures) and mixed with unlabeled, uninfected
recipient macrophages to allow detection of the Lm spreading
to the recipient cells. Similar results were obtained by labeling
donors or recipients with CellTrace Far Red, CmDiI, or DiD and
by staining for major histocompatibility complex class I glyco-
proteins (MHC I) after using donors or recipients from either
BALB/C (Kd) and C57BL/6 (Kb) or b2 microglobulin-deficient
mice (no MHC I) and C57BL/6 (Kb) (data not shown). In all cases,
gentamicin was used to kill cell-free extracellular bacteria.
Gates for quantifying GFP-Lm+ recipients were drawn using
uninfected donors mixed with recipients (Figure 1A). A popula-
tion of recipients became GFP+ when mixed with wild-type
(WT) GFP-Lm-infected donors (Figures 1A and 1B). Visual
inspection by microscopy verified that recipients were infected
with GFP-Lm (see below). Intracellular Lm movement and pseu-
dopod formation within the donors were required for spread
because recipients did not become GFP+ when mixed with
donors infected with ActA-deficient (DActA) GFP-Lm, despite
equivalent primary infection of WT and DActA donors, or when
cytocalasin B was used to block actin polymerization (Figures
1A and 1B). Increasing the number of infected donors or
the incubation time increased the percentage of infected
recipients (Figures 1C and 1D). A ratio of 10:1 recipients:donors
yielded the greatest infection of recipients by WT GFP-Lm
without increasing the background infection of recipients by
DActA GFP-Lm. An incubation of 15–18 hr had the greatest
detection of spread as a result of an increase in transfer from
donors (or recipients) to recipients, an improved ability to detect
secondary infection because of the survival and growth of
transferred GFP-Lm in recipients, or a combination of these.
Together, these studies confirmed that GFP accumulation in
recipients is due to spread from primary infected donors and
enabled us to assay and quantify Lm spread with optimal condi-
tions and sensitivity.808 Immunity 36, 807–820, May 25, 2012 ª2012 Elsevier Inc.TLR Activation of Recipients Increases Their
Susceptibility to Lm Spread as a Result of NO
To evaluate the impact of TLR activation on spread, recipients
were pretreated with agonists for TLR4 (lipopolysaccharide-
LPS), TLR2 (Pam3CSK), TLR3 and RIG-I (PIC), and TLR9
(CpG[+]). Each agonist induced a dose-dependent increase in
GFP+ recipients (Figure 2A). Pretreating recipients with lipotei-
choic acid (LTA), peptidoglycan (PGN), or heat-killed Lm
(HK Lm) likewise increased the ability of Lm to spread from
untreated, WT-Lm-infected donors (Figure 2B). LPS treatment
also increased spreading of Lm asmeasured by plaquing assays
(Figure 2C) and by microscopy-based quantification of the
spreading index (Figures 4A and 4B), confirming that this
increased spread was not an artifact of our flow cyometry-based
assay. LPS and Pam3CSK failed to increase spread when we
used macrophages from MyD88-deficient mice (Myd88/)
and PIC was ineffective at increasing spread when we used
macrophages from Trif-deficient mice (Ticam1/), suggesting
that the respective canonical TLR signaling pathways were
required (Figure 2D). Spread was equally enhanced by pretreat-
ment of recipients alone with LPS or by the addition of LPS when
donors and recipients weremixed (not shown). Increased spread
was first detected after 8 hr of coincubation (Figure 2E). LPS
stimulation did not increase the percentage of GFP+ recipients
when DActA-infected donors were used (Figure 2F). Both the
mean fluorescence intensity (MFI) for GFP-Lm in recipients and
the number of Lm colony-forming units (CFU) recovered from
the cultures increased in parallel with LPS treatment (Figures
2G and 2H), confirming that LPS increased the number of live
Lm within recipient macrophages.
TLR stimulation induced expression of NOS2. We found that
basal spread between NOS2-deficient (Nos2/) donor and
recipient macrophages was significantly (50%) lower than
between C57BL/6 (B6) recipients and donors (Figure 3A). More-
over, LPS did not enhance spread from either B6 or Nos2/
donors into Nos2/ recipients (Figure 3A). Measuring nitrite in
the supernatant confirmed that Nos2/ recipients produced
very little NO (Figure 3B). These findings suggested that induced
NOS2 expression and NO production in recipients was neces-
sary for the TLR-induced enhancement of Lm spread. The
requirement for NOS2 in donor cells was consistent with
a modest induction of NOS2 by Lm infection itself (not shown)
and suggested that some NO might diffuse from these cells to
affect recipients. Indeed, inhibition of NOS2 with either L-nil or
1400W prevented the LPS enhancement of spread between
B6 cells as measured by our flow cytometry assay (Figure 3C)
and reduced nitrite production (Figure 3D). Addition of SNAP,
a NO donor, increased spread from B6 donors to Nos2/
recipients (Figure 3E) and increased nitrite in the supernatant
(Figure 3F). Overall, we observed a strong correlation between
the amount of spread and supernatant nitrite concentrations
(Figure 3G).
We also used a microscopy-based assay to confirm that
nitric oxide production in response to TLR stimulation enhanced
Lm spread. CD45.1 donor cells infected with DActA or WT
GFP-Lm were added to coverslips containing uninfected
C57BL/6 (CD45.2) recipients in media with no treatment, LPS,
LPS+1400W, or SNAP. At 15 hr after the donor cell addition,
the number of infected recipient cells per donor cell was
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Figure 1. Analysis of Lm Spread by Flow Cytometry
To measure spread, 2.5 3 105 unlabeled recipients were mixed with 2.5 3 104 CellTrace Far Red+ donors that were mock, DActA, or WT GFP-Lm infected.
15–18 hr after mixing, cells were collected and analyzed by flow cytometry. Bars indicate standard errors.
(A) Flow cytometry identification of CellTrace Far Red+ donors and unlabeled recipients. In the top panel, donors that wereDActA orWTGFP-Lm infected, but not
mock infected, were GFP-Lm+. In the bottom panel, only recipients incubated with WT GFP-Lm-infected donors were GFP-Lm+. Treatment with cytochalasin B
(CB) blocked actin polymerization and prevented spread from WT donors into recipients.
(B) Quantification of spread into recipients that were mixed with mock, DActA, or WT infected donors alone (untreated) or given CB, n = 5.
(C and D) Spread into recipients was dependent on (C) the donor to recipient ratio, n = 5, and (D) the time of incubation, n = 3. Histograms are representative of all
experiments.
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Nitric Oxide Regulates Lm Spreadapproximately 3-fold higher when LPS or SNAP was added to
the culture, as compared to LPS+1400W or untreated macro-
phages (Figures 4A and 4B). This increased number of infected
cells per donor in the LPS- and SNAP-treated samples corre-
sponded with a 80% reduction in the number of uninfected
cells (Figure 4C), confirming that the difference in numbers of
infected cells was due to increased bacterial spread and donor
cell infection rather than any change in the cell numbers. In
contrast to the enhancement of secondary infection by LPS
treatment, treatment of macrophages with LPS prior to primary
infection inhibited Lm survival and growth in a NOS2-indepen-
dent manner (Figure 4D). This inhibition was observed within6 hr after infection (a time at which very little cell-cell spread is
apparent). These data strongly suggest that TLR stimulation
suppresses primary infection. By contrast, the spreading data
show that TLR-induced NO increases the susceptibility of
macrophages to infection by pseudopod-associated Lm.
NO Delays Phagolysosome Fusion to Promote Lm
Survival in Recipients
NO did not enhance spread by promoting Lm growth in the
cytoplasm, by increasing pseudopod formation by donors or
pseudopod phagocytosis by recipients, nor by directly activating
the Lm hemolysin (Hly) or phospholipases (PlcA or PlcB)Immunity 36, 807–820, May 25, 2012 ª2012 Elsevier Inc. 809
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Figure 2. TLR Stimulation of Recipients Enhances Spread of Lm
(A and B) Flow cytometry analysis for WT GFP-Lm+ recipients 15–18 hr after mixing 2.5 3 105 recipients with 2.5 3 104 WT GFP-Lm-infected donors.
(A) Recipients were treated overnight with various concentrations of TLR ligands (LPS at 0.4, 4, and 40 ng/ml, Pam3CSK4 at 10, 100, and 1,000 ng/ml, poly(I:C)
(PIC) at 40, 200, and 1,000 ng/ml, and CpG() and CpG(+) at 5 and 20 nm), n = 4. TLR stimulation enhanced spread into recipients compared to untreated
(Control).
(B) Recipients were treated overnight with lipoteichoic acid (LTA), peptidoglycan (PGN), or heat-killed (HK) Lm (MOI = 1), washed, and incubated with infected
donors, n = 3.
(C) To confirm the enhancement of spread by TLR ligands measured by flow cytometry, confluent monolayers of macrophages were infected at an MOI of 0.01,
given LPS, washed, and overlayed with agar. 48 hr later, plaque size wasmeasured from images of plates that had been counterstained with neutral red dye. The
average size of plaques was increased by LPS treatment of macrophages, n = 3.
(D) Macrophages from C57BL/6, Myd88/, or Ticam1/ mice were used as recipients. Recipients were treated as in (A) with LPS (40 ng/ml), Pam3CSK4
(1,000 ng/ml), or PIC (1,000 ng/ml), washed, and incubated with infected donors, n = 3.
(E) Time course analyses showed that LPS enhancement of spread occurred after 9 hr of coincubation, n = 3.
(F–H) 2.5 3 104 mock, DActA-, or WT GFP-Lm-infected donors were added to 2.5 3 105 Control () or LPS-treated recipients, incubated for 15–18 hr, and
collected for flow cytomtery.
(F) LPS enhanced spread from WT but not DActA-infected donors, n = 7.
(G and H) LPS also increased then numbers of bacteria in recipients as assessed by (G) the mean fluorescence intensity (MFI) for GFP in recipient cells, n = 6, and
(H) the total Lm CFU in the culture, n = 4.
Bars indicate standard errors.
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Figure 3. TLR-Induced NO Enhances Lm Spread
Flow cytometry analysis for WT GFP-Lm+ recipients and measurement of nitrite in the supernatant 15–18 hr after mixing 2.5 3 105 recipients with 2.5 3 104 WT
GFP-Lm-infected donors. Bars indicate standard errors.
(A) Spread ofWTGFP-Lm fromC57BL/6 (n = 4) or NOS2-deficient (Nos2/, n = 3) donors intoNos2/ recipients was reduced compared to C57BL/6 recipients.
Furthermore, the LPS enhancement did not occur in the absence of NOS2.
(B) Nitrite concentrations in the supernatants, n = 3.
(C and D) The NOS2 inhibitors (Lnil or 1400W) prevented the LPS enhancement of (C) spread (n = 4) and (D) nitrite production (n = 4) from C57BL/6 donors into
C57BL/6 recipients. The NOS2 inhibitors had no effect on the spread or nitrite production from C57BL/6 donors into Nos2/ recipients.
(E and F) SNAP, a NO donor, increased (E) spread into Nos2/ recipients from C57BL/6 donors (n = 4) and (F) the nitrite concentrations, n = 3.
(G) Correlation between the percentage of GFP-Lm+ C57BL/6 recipients and the supernatant nitrite, n = 20.
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Figure 4. NO Is Required for Enhanced Lm Spread but Not Primary Infection
(A and B) Microscopy for DActA (top) or WT (bottom) GFP-Lm CD45.1 recipients 15 hr after plating 5 3 105 recipients with 2.5 3 104 WT GFP-Lm-infected
CD45.1+ donors on coverslips and treating with gentamicin alone (untreated), LPS, LPS+1400W, or SNAP. Pictures of CD45.1+ donors (red) were analyzed for the
number of unlabeled recipients that were infected with WT GFP-Lm (green) or uninfected.
(A) Representative images of infection foci seen after each treatment.
(B) The number of WT GFP-Lm+ recipient per donor (n = 41–47 per treatment) was calculated for each image and the total for each treatment was graphed.
Microscopy confirms the flow cytometry results indicating that LPS and SNAP enhance spread and the requirement for NO in enhanced spread, n = 2.
(C) The number of uninfected recipient per donor (n = 41–47 per treatment) was calculated for each image and the total for each treatment was graphed to verify
that treatments did not affect viability or total cell numbers, n = 2.
(D) The role of LPS was tested in primary Lm infection by plating macrophages on coverslips overnight alone or with LPS. Cells were infected the next day at an
MOI of 1, washed at 1 hr, and treated with gentamicin to prevent growth of bacteria in the media. The number of colony forming units (CFU) was determined by
plating lysates from coverslips collected at 1.5, 3, 6, and 9 hpi. For primary infection, LPS pretreatment suppressed the growth of Lm compared to untreated.
Nos2/ mice showed comparable infection to WT cells, n = 3.
Bars indicate standard errors.
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Nitric Oxide Regulates Lm Spread(Figure S1 available online). Further NO was able to enhance
spread only into cells that could kill Lm during primary infection
(Figure S2). This finding suggested that NO increased spread
by protecting Lm from bactericidal mechanisms in the recipient
cells. Two known bactericidal factors, cathepsin D and the
NADPH oxidase, were protective against secondary infection
but not primary infection. However, neither was responsible for
NO-enhanced spread (Figure S2). We thus hypothesized that
NOmight alter the kinetics of phagosome fusion with lysosomes
in the recipient cells. Indeed, inhibiting phagolysosome fusion by
preventing the acidification of phagosomes with ammonium
chloride (AC) or by directly inhibiting the vacuolar H+-ATPase
via Concanamycin (Con) or Bafilomycin (Baf) increased recipient
cell infection (Figure 5A). Moreover, no further enhancement was
achieved by combining LPS treatment with these agents, and
both Con and Baf treatments significantly enhanced secondary
infection when LPS-induced NO production was blocked with
1400W (Figure 5A). Importantly, AC, Con, and Baf treatments
did not affect nitrite production (Figure 5B). These data sug-
gested that NO regulates spreading Lm survival by decreasing
phagolysosome fusion.
The effects of NO on fusion of phagosomes with lysosomes
were thus quantified by allowing macrophages whose plasma
membrane had been labeled with the PKH dye to phagocytose
either latex or carboxylated beads to mimic uptake of free Lm
or pseudopod-associated Lm (Erwig et al., 2006), respectively
(Figure 5C). PKH+ beads (phagosome-associated) were isolated
from the cells and costained to detect the presence of markers
for early endosomes (Rab5) or lysosomes (Lamp-1) as previously
described (Hmama et al., 2004). This assay revealed rapid accu-
mulation of Rab5 with phagocytosed latex beads, followed by
a steady decrease in Rab5 costaining (Figure 5D). The kinetics
of reduced Rab5 staining was hastened in LPS-treated cells
but this was not affected by 1400W treatment and was thus
independent of NO (Figure 5D). Compared to phagosomes
containing latex beads, phagosomes containing carboxylated
beads had substantially lower Rab5 staining at all time points
analyzed (Figure 5E). This suggested a more rapid maturation
of vacuoles with carboxylated beads into Rab5-negative late en-
dosomes. Indeed, the phagosomes with carboxylated beads
also more rapidly costained with Lamp-1 (compare Figures 5F
and 5G), indicating more rapid fusion with lysosomes. Thus, in
the untreated macrophages, phagosomes containing the pseu-
dopod-like carboxylated beadsmaturedmore rapidly than those
containing free-bacteria-like latex beads. This finding suggests
that secondary phagosomes may normally be more inhospitable
to Lm than primary phagosomes. However, the presence of NO
from LPS or SNAP treatment significantly delayed thematuration
of the carboxylated bead phagosomes—as indicated by the
increased early Rab5 costaining (Figure 5E) and reduced
Lamp-1 costaining (Figure 5G). These effects were independent
of altered protein expression, as shown by the fact that total
cellular Rab-5 amounts were unchanged whereas total cellular
Lamp-1 was increased by LPS or SNAP treatment (data not
shown). Hence, these data argue that NO selectively delays
maturation of phagosomes and the formation of phagolyso-
somes upon engulfment of pseudopod-like particles.
Delayed phagolysosome formation presumably enhances
survival of pseudopod-encapsulated Lm in the recipient cells,possibly by allowing greater intraphagosomal survival and/or
greater bacterial escape from secondary vacuoles. Our flow
cytometry and microscopy data above showed that NO
increased the number of Lm-infected cells during spread, but
these assays did not address whether recipient cells contained
more cytosolic Lm. We therefore used the established method
of quantifying the colocalization of Lm with actin to estimate the
proportion of Lm escaping secondary vacuoles and localizing to
the cytosol of labeled recipient macrophages in the presence
and absence of NO (Figure 6A). LPS treatment significantly
increased the proportion of actin-colocalized Lm in the recipient
cells at 18 hr postinfection (hpi), compared to both the untreated
and LPS+1400W cells (Figure 6B). Moreover, treatment with
1400Wreducedactincolocalizationbelowthat seenwithno treat-
ment, and treatment with the NO donor SNAP was sufficient to
increase the proportion of actin-associated bacteria in the recip-
ient cells (Figure 6B). These data confirm that the ability of NO to
increase Lm spread is associatedwith an enhancement of bacte-
rial escape into the cytoplasm of recipient cells (Figure S3).
Inhibiting NO In Vivo Prevents Lm Spread
The importance of Lm spread for host infection was previously
demonstrated by the observation that ΔActA-Lm are 1,000 times
less virulent thanWT-Lm (Camilli et al., 1993). To confirm that NO
promoted spread in vivo, C57BL/6 mice were treated with saline
or 1400W and infected with either WT or DActA Lm. At 48 hpi,
treatment with 1400W significantly reduced the CFU in the liver
of WT Lm-infected mice (Figure 7A). Treatment with 1400W did
not affect bacterial burdens in the spleens (Figure 7B), where
ΔActA expression has minimal effects on Lm burdens (Camilli
et al., 1993). Bacterial spread in the infected mice was further
evaluated by comparing the ratio of WT to ActA CFU. This anal-
ysis showed that 1400W treatment significantly reduced the
advantage that ActA expression gives Lm in the livers of infected
mice (Figure 7C) but had no effect in mouse spleens. Taken
together, these data support our in vitro finding that NO is impor-
tant for regulating the spread of Lm.
DISCUSSION
Our studies reveal a mechanism by which innate immune
activation increases host susceptibility to infection by Listeria
monocytogenes. Lm and several other pathogens co-opt host
actin polymerization to induce direct cell-cell spread from in-
fected ‘‘donor’’ cells to neighboring uninfected ‘‘recipients.’’
Cell-cell spread by Lm requires ActA, a secreted bacterial factor
that promotes host actin polymerization (Domann et al., 1992;
Kocks et al., 1992). By using quantitative assays we found that
TLR stimulation significantly increased productive Lm infection
of recipient cells via cell-cell spread. The increased infection
required ActA and macrophage nitric oxide (NO) production by
NOS2. NO acted to increase both the percentage of infected
recipients and the number of bacteria per recipient cell but did
not enhance formation of pseudopods or transfer and uptake
of bacteria. Rather, NO delayed phagolysosome fusion when
vacuoles contained particles that resemble host membranes
and increased Lm survival and growth in the recipient cells.
This delay in maturation of secondary vacuoles presumably
increased the ability of Lm to avoid host bactericidal factorsImmunity 36, 807–820, May 25, 2012 ª2012 Elsevier Inc. 813
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Figure 5. NO-Dependent Delay in Phagolysosome Fusion Increases Lm Escape from Secondary Vacuoles, thereby Enhancing Spread
In Vitro and In Vivo
(A and B) Flow cytometry analysis for WT GFP-Lm+ recipients and measurement of nitrite in the supernatant 15–18 hr after mixing 2.5 3 105 recipients with
2.5 3 104 WT GFP-Lm-infected donors.
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Nitric Oxide Regulates Lm Spreadsuch as cathepsin D and the NADPH oxidase. This process is
crucial during systemic Lm infection, where NO production
selectively increased liver burdens of WT but not DActA Lm.
Together, these data reveal how cell-cell spread enables Lm to
exploit innate immune activation during in vitro and in vivo infec-
tion of phagocytes and other bactericidal cells, such as hepato-
cytes (Wing and Gregory, 2002). This mechanism may also
permit subversion of innate immune activation by other bacterial
and viral pathogens capable of cell-cell spread.
The ability of TLR stimulation and NO production to enhance
host susceptibility to Lm was limited to infection via cell-cell
spread. Multiple lines of evidence indicate that infection via
cell-cell spread is mechanistically distinct from direct infection.
For example, electron microscopy shows that spreading Lm
are initially contained by a double membrane vacuole, whereas
Lm taken up from the extracellular environment are contained
by a single membrane vacuole (Tilney and Portnoy, 1989). In
addition, the secreted Lm enzyme PlcB is selectively required
for escape from secondary but not primary vacuoles (Camilli
et al., 1993; Poussin and Goldfine, 2005). The unique features
of infection via cell-cell spread probably explain why NO
uniquely impacts Lm infection via this route, and therefore we
considered whether NO might act by enhancing the function of
virulence factors such as PlcB. However, we failed to see any
effect of NO on PlcB activity in Lm supernatants by using a color-
imetric phospholipase assay. Conversely, NO directly inhibited
hemolytic activity of Hly in Lm supernatants. Hly function is
required for Lm escape from both primary and secondary vacu-
oles (Alberti-Segui et al., 2007; Burrack et al., 2009; Gedde et al.,
2000; Portnoy et al., 1988). Thus, the observed inhibition of Hly
activity in vitro might be expected to correspondingly inhibit
both primary and secondary Lm infection in NO-producing
macrophages. The fact that we failed to observe such inhibition
suggests that (1) nitric oxide does not directly interact with Hly
during infection of macrophages, (2) the inhibition of Hly (and
possibly escape) by nitric oxide measured in vitro is below the
threshold required for biologically relevance, (3) the potential
antibacterial effects of impairing Hly function are counteracted
by other effects of NO, such as altering the rate of phagolyso-
some fusion, or (4) the ability of NO to directly inhibit hemolytic
activity in vitro might be counteracted by other host cell factors,(A) Inhibiting phagosomal acidification with Concanamycin (Con), Bafilomycin (B
secondary infection but did prevent the inhibition of spread by LPS+1400W, n =
(B) Inhibiting phagosomal acidification did not impact nitrite production, n = 6.
(C–G) Flow cytometry analysis was performed to determine the rate of digestion
nized uptake of latex beads (mimic free Lm for primary infection) or carboxylat
membrane-labeled macrophages that were untreated, pretreated overnight with
were collected and stained for the early endosomal marker Rab-5 or the lysosom
(C) Flow cytometry plots depicting how beads were identified by forward and side
PKH-membrane dye.
(D and E) Colocalization of phagocytosed beads with the early endosomal mark
(D) Mean fluorescence intensity (MFI) for Rab-5 staining on phagocytosed PKH
reduced by SNAP treatment, n = 3.
(E) The MFI for Rab-5 on carboxylated beads that mimic secondary infection wa
(F and G) Colocalization of phagocytoses beads with the lysosomal marker Lam
(F) MFI for Lamp-1 on phagocytosed PKH+ latex beads (primary infection) was n
(G) NO induced by LPS or SNAP reduced the colocalization of phagocytosed ca
MFI for Lamp-1, n = 4.
Bars indicate standard errors.such as the g-interferon-inducible lysosomal thiol (GILT) (Singh
et al., 2008). NO reportedly can suppress primary vacuolar
escape by another intracellular bacterial pathogen, Francisella
tularensis (Tancred et al., 2011), although the suppressionmech-
anism is in this case pathogen specific. Thus, it is conceivable
that NO prevents Lm invasion of the cytoplasm during direct
infection and that the Lm growth we observed occurs in vacu-
oles, as previously shown (Birmingham et al., 2008). However,
Lm clearly accessed the cytosol after infection of NO-producing
cells via cell-cell spread. Hence, our findings argue against the
notion that NO increases bacterial spread by increasing bacterial
virulence factor function and instead point to unique effects of
NO on the maturation of secondary vacuoles containing
membrane-encapsulated bacteria.
Why do secondary vacuoles traffic differently than those
formed around extracellular bacteria? We hypothesize that
Lm-containing pseudopods mimic apoptotic bodies and thus
co-opt the process of ‘‘efferocytosis.’’ Under normal circum-
stances, efferocytosis is noninflammatory and nonimmunogenic
and vacuoles containing phagocytosed apoptotic cells very
rapidly fuse with lysosomes (Erwig and Henson, 2008; Erwig
et al., 2006). As we show here, the production of NO delays
this maturation. Perhaps NO acts to signify an inflammatory
environment in which the selective delay in digestion of dying
(infected) cells permits enhanced processing and presentation
of microbe antigens. It remains unclear precisely how NO
selectively attenuates secondary vacuole maturation. TLR
stimulation alters phagosomematuration by raising phagosomal
pH and lowering degradative capacity (Yates et al., 2007), but it
is unclear whether NO is responsible for these effects. NO
directly and reversibly inhibits the vacuolar H+-ATPase (Forgac,
1999; Swallow et al., 1991; Tojo et al., 1994), which could delay
maturation of secondary vacuoles. Consistent with this interpre-
tation, blocking of the vacuolar H+-ATPase with Con or Baf to
some extent mimicked the effects of NO. However, we cannot
exclude the possibility that NO acts by another mechanism,
such as direct modification of Rab proteins or indirect activation
of protein kinase G (Akaike et al., 2010; Francis et al., 2010).
TLR stimulation of macrophages or stimulation with the ‘‘clas-
sical’’ combination of LPS+IFN-g dramatically curtails direct Lm
infection (MacKaness, 1964; Portnoy et al., 1989; Myers et al.,af), or ammonium chloride (AC) did not change untreated or LPS-enhanced
6.
of beads phagocytosed by PKH-membrane-labeled macrophages. Synchro-
ed beads (mimic pseudopod-contained Lm for secondary infection) by PKH-
LPS or LPS+1400W, or given SNAP 30 min prior to starting the assay. Lysates
al marker Lamp-1 at 0, 30, 60, or 90 min after phagocytosis.
scatter. Phagocytosed beads were identified by their staining for macrophage
er Rab-5.
+ latex beads that mimic primary infection was not affected by LPS, but was
s increased by LPS or SNAP treatment that induce NO, n = 3.
p-1.
ot affected by NO, n = 4.
rboxylated beads (secondary infection) with the lysosome as measured by the
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To measure WT GFP-Lm secondary infection, 2.5 3 105 unlabeled recipients were mixed with 2.5 3 104 CellTrace Far Red+ donors that were WT GFP-Lm
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Figure 7. NO Contributes to Enhanced Bacterial Spread In Vivo
C57BL/6 mice were treated with saline or 1400W and infected with either WT or DActA Lm. Mice were harvested 48 hpi.
(A) CFU in the liver of mice shows that there is a decrease in WT CFU when mice were treated with 1400W.
(B) CFU in the spleen.
(C) The ratio of WT to DActA CFUwas calculated as ameasure of Lm spread for the liver and spleen of saline or 1400W-treatedmice. Enhanced spread was seen
in the liver compared to the spleen. Treatment with 1400W significantly reduced Lm spread in the liver. Data points represent each mouse, means ± SEM from all
mice. n = 5 mice per experiment, performed twice.
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Nitric Oxide Regulates Lm Spread2003; Shiloh et al., 1999). A prior microscopy-based study sug-
gested that this impairment in J774macrophages was due to the
ability of NO to limit Lm escape from primary vacuoles (Myers
et al., 2003). However, our data suggested that any suppressive
effect of NO on Lm escape from primary vacuoles is insufficient
to prevent normal Lm intracellular replication. Moreover, others
found that NOS2 is dispensable for killing of Lm by IFN-g-acti-
vated macrophages and that Nos2/ mice are only modestly
more susceptible to systemic Lm infection (Edelson andUnanue,
2002; Endres et al., 1997; Gregory et al., 1993; Shiloh et al.,
1999). In one study, NOS2 expression even appeared to impair
bacterial killing (Edelson and Unanue, 2002). Given the ability
of IFN-g to strongly induce NO production, it was thus surprising
that macrophages treated with IFN-g were not susceptible to
enhanced Lm spread (and even resisted spread a bit). This result
indicated that IFN-g administered alone to macrophages can
trump the probacterial effects of NO production. Presumably,
this trumping is due to induction of other antimicrobial effectors
by IFN-g, such as the p65 GTPases that modulate vacuolar
traffic and thus the killing of Lm in both primary and secondary
vacuoles (Kim et al., 2011). By contrast, when IFN-g was added
with LPS, it failed to prevent NO-dependent increases in recip-
ient cell infection with Lm via cell-cell spread. This result indi-
cates that the effects of LPS stimulation trump those of IFN-g
during cell-cell spread. We speculate that TLR signals (or signals
induced by TLR-stimulated factors such as IFN-ab, IL-6, or
TNF-a) impair the induction of p65 GTPases or other potentially
protective responses by IFN-g. Prior studies from our lab and
others support this model in that they show the ability of IFN-b
to suppress macrophage gene induction in response to IFN-g
(Rayamajhi et al., 2010).
The contribution of NO to host protection can be critical, ancil-
lary, deleterious, or imperceptible (Nathan, 1997). We showed(A) Representative images of GFP-Lm (green) colocalization with actin (red) in
untreated or given LPS, LPS+1400W, or SNAP. Arrows in the enlarged picture in
(B) Graph of the analysis of images described in (A). The proportion of GFP-Lm co
LPS+1400W at 18 hr postmixing with infected donors, n = 3.here that NO production in response to TLR activation can
benefit Lm by enhancing pathogen spread to increase bacterial
burdens during systemic infection. NO production also appears
to increase susceptibility in models of Shigella infection
(MacMicking et al., 1997) and could contribute to the enhanced
susceptibility of mice exposed to zymosan or influenza to infec-
tion by Lm (Jamieson et al., 2010; Young et al., 2009). Excessive
NO production might also contribute to the increased incidence
of Listeriosis in patients with solid organ transplants, liver
disease, diabetes, andmalignancy (Bennion et al., 2008; Ferna`n-
dez-Sabe´ et al., 2009). NADPH oxidase and Cathepsin D were
previously reported to inhibit Lm infection, but under conditions
where it was unclear whether inhibition occurred at the level of
primary or secondary infection (del Cerro-Vadillo et al., 2006;
Myers et al., 2003; Shiloh et al., 1999). Our findings here revealed
selective antibacterial effects of these factors during secondary
infection and thus indicate that macrophages do possess mech-
anisms for counteracting cell-cell spread. Enhancing NADPH
oxidase and Cathepsin D activity may thus have selective effi-
cacy in therapy of infections by microbes capable of cell-cell
spread. Future efforts to determine when, where, and how innate
immune activation increases host susceptibility to pathogens
may reveal additional targets for therapeutic inhibition during
infectious and inflammatory diseases.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice for in vitro experiments were from Jackson Laboratories.
Nos2/ mice were from Jackson (B6.129P2-Nos2tm1Lau/J) or Taconic
(B6.129S2-Nos2tm1MrI N12). Mice from Jackson Laboratories were used for
in vivo experiments. myd88/ mice were provided by T. Leslie at National
Jewish Health (Suram et al., 2010; Takeuchi et al., 1999). Trif-deficient mice
were a gift from P. Marrack at National Jewish Health. The Institutional Animalthe cytoplasm of CellTrace Far Red+ recipient (blue) macrophages that were
dicate colocalization.
localizing with actin was increased by LPS and SNAP compared to untreated or
Immunity 36, 807–820, May 25, 2012 ª2012 Elsevier Inc. 817
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Reagents
Cells were labeled with CellTrace Far Red, CMDiI, and DiD (Invitrogen) at 0.5,
5, and 5 mM according to manufacturer’s instructions. In brief, for CellTrace
Far Red, cells were lifted with ice-cold dPBS, centrifuged, and resuspended
at 5 3 106/ml. CellTrace Far Red was added to final concentration of 0.5 mM
and cells were incubated at 37C for 5 min. An equal volume of bone marrow
media was added to stop reaction. Cells were washed twice with media before
being used in assays. For CMDiI and DiD labeling, the appropriate volume
of dye was added to macrophages growing in 15 cm dish in bone marrow
media for 5–15 min in incubator. Media was removed, cells were washed
twice with warm dPBS, and cells were lifted with ice-cold dPBS and used
for assays. Phallodin (1:300) was from also from Invitrogen. LPS (#201 from
E. coli 0111:D4) was from List Biological Laboratories. Pam3CSK, CpG(),
and CpG(+) oligomers (ODN 1826, (+) 50-tccatgacgttcctgacgtt-3 and (-)
50-tccatgagcttcctgagctt-30) were from InVivoGen. Cytochalasin B (CB, 3 mM)
and concanamycin (Con, 10 ng/ml) were from Enzo. Bafilomycin (Baf,
0.5 mM) was from Alexis. PKH, poly(I:C) (PIC), erythromycin (erm), ammonium
chloride (AC, 10 mM), lipoteichoic acid (LTA, 10 mg/ml), peptidoglycan (PGN,
50 ng/ml), and Nozyme were from Sigma. S-Nitroso-N-acetyl-DL-penicilla-
mine (SNAP), 1400W (10 nM), and Lnil (70 nM) were from Caymen. Gentamicin
(gent) was from Hyclone. Tryptic Soy Broth (TSB) and bactoagar were from
BD. Biotinylated anti-Lamp-1 (1:100) and streptavidin-Alexa 780 (1:300)
were from Ebioscience. Anti-Rab-5 (1:100) was from Santa Cruz.
Cell Culture
Bone marrow-derived macrophages (BMM) were lifted with ice-cold dPBS
and plated 6–7 days after culturing marrow from mice on 150 mm plastic
dishes in media (DMEM+20% Bovine Growth Serum [Hyclone], 10% L929-
conditioned media, 2 mM L-glutamine, 1 mM sodium pyruvate, and 55 mM
b-ME) at 37C and 7.5% CO2.
Bacteria
WT,DActA, andDHly strains of Lm (10403S background) were fromD. Portnoy
(UCBerkeley). Each strain was engineered to expressGFP by transfectionwith
expression plasmid pNF8, which contains GFP and a selectable erm resis-
tance gene (Fortinea et al., 2000). Colonies from fresh LB agar plates were
grown to log phase in TSB with 15 mg/ml erm at 37C with shaking. Lm were
collected, washed, and resuspended in dPBS. CFU was calculated by
measuring the absorbance of the supernatant at 600 nm with the formula
OD 0.3 = 5 3 108 CFU/ml. Heat-killed (HK) Lm was prepared by incubating
log phase Lm at 67C for 3 hr.
Primary Lm Infection and Growth Assay
Cells were plated overnight on glass coverslips in a 60 mm petri dish either
alone or with treatment. Macrophages were infected at an MOI of 1 for 1 hr,
washed twice with dPBS, and media with 50 mg/ml gent was added. For
some experiments, 200 mM SNAP was added at 1.5 hpi. Three coverslips
per group were collected at 1.5, 3, 6, and 9 hpi. Cells were lysed in 5 ml
H20, plated onto 10 cm LB agar plates, and grown overnight at 37
C.
Secondary Lm Infection Assay
To quantify Lm secondary infection, spread assays were performed by mixing
uninfected recipients with infected donors on 96-round bottom plates or glass
coverslips. Recipients (2.5 3 105/assay) were either plated overnight with
stimuli or collected immediately prior to use. Donors were infected at an
MOI of 10–20 for 1 hr and washed twice with dPBS, and media with 50 mg/ml
gent was added. Donors were collected 1–2 hr after gent treatment via
Nozyme, centrifuged and mixed with recipients in media with erm (15 mg/ml)
and gent (10–50 mg/ml) at a ratio of 1:10 for donor:recipient, and collected at
15–18 hr post mix unless otherwise stated. Duplicates were used for each
condition. Cytochalasin B, SNAP, 1400W, and Lnil were added when cells
were mixed and were present for the duration of the spread assay.
For analysis by FACS, cells in 96-well plates were centrifuged, washed once
with dPBS, centrifuged and treated with Nozyme, and centrifuged, and the cell
pellet was resuspended in dPBS and then fixed with 2%–4% buffered formal-818 Immunity 36, 807–820, May 25, 2012 ª2012 Elsevier Inc.dehyde. 10,000 events were captured for each sample. Data were analyzed by
gating on recipient cells and determining the percentage of GFP+ recipients for
all samples via the gate drawn from the untreated, control recipients mixed
with mock-infected donors. The percent GFP+ recipients seen when WT
GFP-Lm-infected donors were used varied from 18% to 70% depending on
the experiment. As a result of this variability, the percent control spread was
calculated for each experiment by dividing the %GFP+ recipients for each
treatment by the %GFP+ recipients for the control 3 100.
For confirmation of the flow cytometry results, CD45.1 C57BL/6 congenic
macrophages were infected with Lm at an MOI of 10. After 1 hr, donors
were washed, incubated with 50 mg/ml gent and 15 mg/ml erm for an additional
1 hr, lifted with Nozyme, and mixed with C57BL/6 recipient macrophages
on coverslips at a 1:20 ratio. After 15 hr, coverslips were rinsed and surface
stained with anti-mouse CD45.1 Cy5 (eBioscience) before being fixed
with 4% paraformaldehyde. After fixation, coverslips were stained with
Alexa Fluor 546 Phalloidin (Invitrogen) and DAPI and mounted to slides.
Coverslips were imaged with a 403 air objective on a Leica DM RXA
microscope. For each of two independent experiments, 25–35 image fields
containing at least one, but no more than two, donors were obtained for
each sample condition by Slidebook software. Images were collected and
analyzed in a blinded manner. Imaging of the phalloidin channel was used to
identify and confirm the perimeter of infected cells. However, we found
that our ability to visualize bacteria residing in differing z planes of the image
was improved when slides were examined without visible phalloiding (as in
Figure 4). For the blind analysis, the total number of (CD45.1+) donor and
(CD45.1) recipient cells per image field was counted together with the
number of infected cells and the number of uninfected cells. After decoding
of images, the ratio of infected recipients per donor was used to compare
spreading efficiency between the treatments. Essentially identical data
were obtained if we instead compared the ratio of uninfected cells per donor.
Analysis of the two experiments separately or when pooled gave identical
results.
Plaque Assays
For plaquing, confluent monolayers of macrophages in 12-well plates were
infected at an MOI of 0.01 with log phase WT Lm similar to the previously
described method (Sun et al., 1990). 1 hr later, cells were washed twice with
PBS and gent (10 mg/ml) was added along with nothing or 4 ng/ml LPS. Cells
were washed three times 1 hr later and 0.7% agarose was added to each well.
Plates were collected 48 hr postinfection and counterstained with neutral red
dye. Plates were imaged with a HP desktop scanner. Plaques from deidenti-
fied pictures of each well were measured with Adobe Photoshop.
Quantification of Lm in Cytoplasm of Infected Recipients
GFP-Lm-infected donors were added to CellTrace Far Red+ recipients on
glass coverslips. Coverslips were harvested, fixed with 4% paraformaldehyde
and 3% sucrose in dPBS, permeabilized with 0.2% Triton X, and stained with
phallodin 544 and Hoechst before being mounted onto slides. Z stack images
were collected with a Zeiss 200M-Marianas system microscope (3i) with a
633 oil objective and Sedat filters via Slidebook software. 30–80 recipients
per conditionwere analyzed for GFP-Lm colocalizationwith actin using decon-
voluted projection images viewed in Adobe Photoshop. After decoding of
images, the number of Lm colocalized with actin for each treatment was
graphed.
Mouse Infections
Female mice (6–8 weeks old) were infected (tail vein) with 0.5–2 3 104 CFU of
log-phase mouse passaged WT or DActA Lm. Mice received i.p. injection of
saline or 1400W (10 mg/kg) at 0 and 24 hpi. Blood, spleen, and liver were
harvested at 48 hpi. CFU were determined by dilution plating as previously
described (Rayamajhi et al., 2010).
Quantification of Phagolysosome Fusion
PKH-labeled macrophages were plated (6-well plates) and treated overnight
with nothing, LPS, or LPS+1400W. Cells were pretreated with 200 mM SNAP
for 30 min. Latex or carboxylated beads (8 3 106 per well, 4 mm in diameter,
Invitrogen) were bound to cells at 4C for 45min. Cells were washed four times
with dPBS and prewarmedmedia was added. Cells were collected at 0, 30, 60,
Immunity
Nitric Oxide Regulates Lm Spreadand 90 min and lysates were collected as previously described (Hmama et al.,
2004) and stained with Fixation and Permeabilization buffers (eBioscience).
Greiss Reaction
100 ml of supernatant was mixed with 100 ml of 1% sulfanilamide, 0.1% naph-
thylethylene diamine, and 2.5%H3PO4. Absorbance wasmeasured at 540 nm.
Concentration was determined based on a standard curve via NaNO2.
Flow Cytometry
Cells were analyzed by flow cytometry with the FACScan running on CellQuest
software (BD Biosciences) and plots were rendered with FlowJo software
(Tree Star, Inc).
Statistics
Statistical analysis and p value calculations were conducted with the Prism 4
statistical program (GraphPad Software). One-way ANOVA followed by Tukey
tests were performed. Data represent means ± SEM of n individual experi-
ments. Samples with an asterisk indicate a p value less than 0.05.
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